Effects of aromatase inhibitors letrozole and anastrazole on bone metabolism and steroid hormone levels in intact female rats

Gynecological Endocrinology

Volumn 23, Issue 10, 2007, Pages 556-561

  Kumru, Selahattin ^a   Yildiz, Azer A ^a   Yilmaz, Bayram ^b   Sandal, Suleyman ^a   Gurates, Bilgin ^a  

^a FIRAT UNIVERSITY   (Turkey)

^b YEDITEPE UNIVERSITY   (Turkey)

Author keywords

Anastrazole; Bone; Letrozole; Osteocalcin; Pyridinoline; Rat

Indexed keywords

ANASTROZOLE; ANDROSTENEDIONE; AROMATASE INHIBITOR; ESTRADIOL; LETROZOLE; OSTEOCALCIN; PRASTERONE; PRASTERONE SULFATE; PYRIDINOLINE; STEROID HORMONE; TESTOSTERONE;

ANDROSTENEDIONE BLOOD LEVEL; ANIMAL EXPERIMENT; ARTICLE; BONE DENSITY; BONE METABOLISM; BONE TURNOVER; CONTROLLED STUDY; DRUG MECHANISM; DRUG MEGADOSE; ESTRADIOL BLOOD LEVEL; FEMALE; FEMUR; NONHUMAN; PRIORITY JOURNAL; RAT; SPINE; TESTOSTERONE BLOOD LEVEL;

AMINO ACIDS; ANIMALS; AROMATASE INHIBITORS; BONE DENSITY; DEHYDROEPIANDROSTERONE SULFATE; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; NITRILES; OSTEOCALCIN; RATS; TESTOSTERONE; TRIAZOLES;

EID: 35348948901     PISSN: 09513590     EISSN: 14730766     Source Type: Journal    
DOI: 10.1080/09513590701557119     Document Type: Article

References (27)

1. Kumru S, Aydin S, Aras A, Gursu MF, Gulcu F. Effects of surgical menopause and estrogen replacement therapy on serum paraoxonase activity and plasma malondialdehyde concentration. Gynecol Obstet Invest 2005;59:108-112.
2. Kumru S, Godekmerdan A, Yilmaz B. Immune effects of surgical menopause and estrogen replacement therapy in perimenopausal women. J Reprod Immunol 2004;63:31-38.
3. Ribot C, Tremollieres F, Pouilles JM. Aromatase and regulation of bone remodeling. Joint Bone Spine 2006;73:37-42.
4. Simpson ER, Mahendroo MS, Means GD, Kilgore MW, Hinshelwood MM, Graham-Lorence S, Amarneh B, Ito Y, Fisher CR, Michael MD, et al. Aromatase cytochrome P450, the enzyme responsible for estrogen biosynthesis. Endocr Rev 1994;15:342-355.
5. McCloskey E. Effects of third-generation aromatase inhibitors on bone. Eur J Cancer 2006;42:1044-1051.
6. Attar E, Bulun SE. Aromatase inhibitors: the next generation of therapeutics for endometriosis? Fertil Steril 2006;85:1307-1318.
7. Bulun SE, Imir G, Utsunomiya H, Thung S, Gurates B, Tamura M, Lin Z. Aromatase in endometriosis and uterine leiomyomata. J Steroid Biochem Mol Biol 2005;95:57-62.
8. Holzer H, Casper R, Tulandi T. A new era in ovulation induction. Fertil Steril 2006;85:277-284.
9. Ma BB, Oza A, Eisenhauer E, Stanimir G, Carey M, Chapman W, Latta E, Sidhu K, Powers J, Walsh W, et al. The activity of letrozole in patients with advanced or recurrent endometrial cancer and correlation with biological markers - a study of the National Cancer Institute of Canada Clinical Trials Group. Int J Gynecol Cancer 2004;14:650-658.
10. Reich O, Regauer S. Hormonal treatment with aromatase inhibitors for patients with endometrial stromal sarcoma. Gynecol Oncol 2005;98:173-174.
11. Eastell R, Hannon R. Long-term effects of aromatase inhibitors on bone. J Steroid Biochem Mol Biol 2005;95:151-154.
12. Goss PE, Qi S, Cheung AM, Hu H, Mendes M, Pritzker KP. Effects of the steroidal aromatase inhibitor exemestane and the nonsteroidal aromatase inhibitor letrozole on bone and lipid metabolism in ovariectomized rats. Clin Cancer Res 2004;10:5717-5723.
13. Ailawadi RK, Jobanputra S, Kataria M, Gurates B, Bulun SE. Treatment of endometriosis and chronic pelvic pain with letrozole and norethindrone acetate: a pilot study. Fertil Steril 2004;81:290-296.
14. Heshmati HM, Khosla S, Robins SP, O'Fallon WM, Melton LJ, Riggs BL. Role of low levels of endogenous estrogen in regulation of bone resorption in late postmenopausal women. J Bone Miner Res 2002;17:172-178.
15. Harper-Wynne C, Ross G, Sacks N, Salter J, Nasiri N, Iqbal J, A'Hern R, Dowsett M. Effects of aromatase inhibitor letrozole on normal breast epithelial cell proliferation and metabolic indices in postmenopausal women: a pilot study for breast cancer prevention. Cancer Epidemiol Biomarkers Prev 2002;11:614-621.
16. Amsterdam LL, Gentry W, Jopanputra S, Wolf M, Rubin S, Bulun SE. Anastrazole and oral contraceptives: a novel treatment for endometriosis. Fertil Steril 2005;84:300-304.
17. Bajetta E, Zilembo N, Dowsett M, Guillevin L, Di Leo A, Celio L, Martinetti A, Marchianò A, Pozzi P, Stani S, et al. Double-blind, randomised, multicentre endocrine trial comparing two letrozole doses in postmenopausal breast cancer patients. Eur J Cancer 1999;35:208-213.
18. Ziegler D. The dawning of the non-cancer uses of aromatase inhibitors in gynaecology. Hum Reprod 2003;18:1598-1602.
19. Shozu M, Murakami K, Segawa T, Kasai T, Inoue M. Successful treatment of a symptomatic uterine leiomyoma in perimenopausal woman with a nonsteroidal aromatase inhibitor. Fertil Steril 2003;79:628-631.
20. Cortinez A, Carvalho ID, Vantman D, Gabler F, Iniquez G, Vega M. Hormonal profile and endometrial morphology in letrozole-controlled ovarian hyperstimulation in ovulatory infertile patients. Fertil Steril 2005;83:110-115.
21. Garnero P, Delmas PD. Biochemical markers of bone turnover. Applications for osteoporosis. Endocrinol Metab Clin North Am 1998;27:303-323.
22. Okman TK, Kucuk M, Altaner S. Comparison of the effects of letrozole and clomifhene citrate on ovarian follicles, endometrium and hormone levels in the rat. Fertil Steril 2003;80:1330-1332.
23. Vanderschueren D, Bouillon R. Androgens and bone. Calcif Tissue Int 1995;56:341-346.
24. Remes T, Vaisanen SB, Mahonen A, Huuskonen J, Kroger H, Jurvelin JS, Penttila IM, Rauramaa R. The association of bone metabolism with bone mineral density, serum sex hormone concentrations, and regular exercise in middle-aged men. Bone 2004;35:439-447.
25. Zofkova I, Bahbouh R, Hill M. The pathophysiological implications of circulating androgens on bone mineral density in a normal female population. Steroids 2000;65:857-861.
26. Bajetta E, Zilembo N, Bichisao E. Endocrine effects of nonsteroidal aromatase inhibitors and their clinical impact. J Clin Oncol 2002;20:3039-3040.
27. Speroff L, Marc AF. Menapause and the perimenopausal transition. In: Weinberg RW, editor. Clinical gynecologic endocrinology and infertility. 7th ed. Philadelphia (PA): Lippincott Williams-Wilkins; 2005. pp 621-688.